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Abstract
Background: Vagus nerve stimulation (VNS) using non-invasive approaches have attracted great attention due to their anti-epileptic, anti-depressive and procognitive effects. It has been proposed that auricular transcutaneous VNS (atVNS) could benefit intellectual disability disorders, but preclinical data supporting this idea is limited.
Objective: To develop an atVNS device for mice and to test its efficacy on memory performance in naïve mice and in a mouse model for intellectual disability.
Methods: Naïve outbreed CD-1 mice and a model for fragile X syndrome, the Fmr1 knockout (Fmr1KO), were used to assess the effect of atVNS in the novel objectrecognition memory performance.
Results: We found that atVNS significantly improves memory persistence in naïve mice. Notably, atVNS was efficacious in normalizing the object-recognition memory deficit in the Fmr1KO model. Conclusion: Our data show that atVNS improves memory persistence in naïve mice and in a model of intellectual disability and support further studies taking advantage of preclinical mouse models of cognitive disorders.
Introduction
The vagus nerve (cranial nerve X) contains mostly afferent fibers (80%) carrying sensorial inputs from visceral organs and superficial areas [1] . Vagus nerve electrostimulation (VNS) through invasive approaches has shown effectiveness in controlling refractory epilepsy, as a co-adjuvant in the treatment of major depression, and the improvement of cognitive performance [1, 2] . The innervation of the external ear is supplied by a heterogeneous distribution of cranial branchial nerve and somatic cervical nerves [3] . The helix of the auricle is mainly supplied by the auriculotemporal nerve (91%) and to a minor extent by the great auricular nerve (9%) [3] , while the cymba conchae is entirely (100%) supplied by the auricular branch of the vagus nerve (ABVN) [3] , which makes it a readily accessible site for electrostimulation. In rats, the ABVN emerges from the superior ganglion [4] and terminates in the nucleus of the tractus solitarius (NTS) of the brainstem [5] . As the therapeutic effects of invasive VNS involve the activation of the NTS, the ABVN has gained interest as a target for non-invasive auricular transcutaneous vagus nerve stimulation (atVNS) [1] .
Neurodevelopmental disorders resulting in intellectual disability may benefit from non-invasive VNS. Unfortunately, adequate VNS set-ups combined with relevant behavioral outcomes are not currently available for well-established animal models of cognitive disorders which hampered the possibility of producing a thorough preclinical assessment. Fragile X syndrome is the most common monogenic cause of inherited intellectual disability and autism produced by the silencing of the FMR1 gene [6] . The constitutive knockout mouse for the Fmr1 gene (Fmr1KO) [7] shows significant cognitive alterations [8, 9] and has been long used as a well-accepted tool for experimental therapeutic assessment [10] .
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In this study, we designed, produced and tested the effect on memory persistence of a non-invasive auricular stimulator for mice. Our data further support the relevance of atVNS in cognitive modulation in naive mice and in a model of intellectual disability.
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Materials and methods

Animals
Young-adult male CD-1 mice (10-12 weeks old) were purchased from Charles River Laboratories (France). Young-adult Fmr1KO mice (12-14 weeks old) and wildtype (WT) littermates in a C57BL/6J congenic background (B6.129P2-Fmr1 tm1Cgr /J) [7] were bred at the Barcelona Biomedical Research Park (PRBB)
Animal Facility. All animal procedures were conducted in accordance with the standard ethical guidelines (European Communities Directive 2010/63/EU). Mice were housed in a temperature-controlled (21 ± 1 °C) and humidity-controlled (55 ± 10%) environment. Lighting was maintained at 12 hours cycles (on at 8 AM and off at 8 PM). Food and water were available ad libitum. Mice were handled for 1
week before starting the experiment. All behavioral experiments were performed by experimenters blind to the experimental conditions.
Electrode system
The electrode prototype was based in a description of a setup for atVNS in rat [5] .
Briefly, silver wires with a diameter of 0.5 mm were mounted on a newly designed transparent methacrylate surface and fixed with epoxy resin ( Figure 1A ).
Stimulation parameters
Rectangular bipolar pulses were delivered with a Beurer EM49 stimulator (Beurer, Germany). The stimulation parameters were: 1 mA, 20 pulses/second, 30 seconds ON and 5 min OFF, total length of 30 min, with 330 μs pulse width [5, 11] .
Current delivery was monitored using a Hantek DSO8060 oscilloscope (Qingdao
Hantek Electronic, China), measuring the voltage drop across an external reference Figure 1B) to avoid cardiac complications, as the right branch of the vagus nerve innervates the sinoatrial node and can have undesirable effects on heart rate [12] . For sham condition, electrodes were placed on the helix of the left auricle, outside of the ABVN innervated area. For the "no stimulation" condition mice were anesthetized, but no electrical stimulation was delivered.
True atVNS, sham stimulation and no stimulation procedures were performed immediately after the familiarization phase of the novel object-recognition test.
Novel object-recognition memory test
Object-recognition memory was assayed as described previously [13] ( Figure 1C ).
Briefly, on the first day, mice were habituated to an empty V-shaped maze (Vmaze) for 9 min (habituation phase). Then, on the second day, mice were introduced into the V-maze where two identical objects were presented for 9 min (familiarization phase). Immediately after the familiarization phase, mice were exposed to one of the following conditions: (atVNS condition, sham condition or no stimulation) as described above. Then, on the third day, the memory persistence test was performed. To this end, one familiar and one novel object were presented Brain Stimulation: Techniques and methods BRS-D-19-00781R1 7 to the mice for 9 min in the V-maze. In naïve CD-1 mice, object-recognition memory was tested 48 h after the familiarization phase, a time at which memory persistence enhancements can be measured. In the case of the fragile X syndrome model, memory persistence was tested 24 h after the familiarization phase, at a time when Fmr1KO mice show a significant memory impairment [14] . Time exploring both novel and familiar objects was considered as the time mice spent within 2 cm from the object and with their nose facing it. The exploration time was used to calculate the discrimination index (DI): the difference between the exploration time for the novel and the familiar object related to the time exploring both objects. Higher discrimination indexes were considered to reflect greater object-recognition memory persistence.
Statistical analysis
Data were analyzed with Statistica Software using one-way analysis of variance (ANOVA) or repeated-measures two-way ANOVA for multiple group comparison.
Subsequent post-hoc analysis (Newman-Keuls) was used when required (significant interaction between factors). Comparisons were considered statistically significant when p < 0.05. Data are represented as mean ± standard error of the mean (s.e.m.).
Results
atVNS improves novel object-recognition memory performance in naïve mice
We first assessed the effect of atVNS in cognitive function in naïve CD-1 mice.
atVNS condition showed a significantly improvement in object-recognition memory performance at 48 h as revealed by the discrimination index values for the different experimental groups (atVNS = 0.37 ± 0.05; Sham = 0.19 ± 0.03, p = 0.01; No stimulation = 0.21 ± 0.05, p = 0.03) (Figure 2A ), while sham condition reproduced the data on discrimination indexes obtained in mice that did not receive any electrostimulation (Sham = 0.19 ± 0.03; No stimulation = 0.21 ± 0.05, p = 0.84) (Figure 2A) . No differences were observed in overall exploration during the memory test phase ( Figure 2B ).
To discard possible confounding effects of anesthesia in the consolidation of novel object-recognition memory delivered after the familiarization session, we assessed object-recognition performance in anesthetized and non-anesthetized naïve mice.
Discrimination indexes corresponding to object-recognition memory tested 48 h showed no difference between experimental groups (Basal = 0.18 ± 0.02; Isoflurane = 0.20 ± 0.03, p = 0.65) ( Figure 2C ). As expected, there were no differences in exploratory behavior during the memory test phase ( Figure 2D ).
atVNS improves novel object-recognition memory performance in Fmr1KO mice
We used the Fmr1KO as a model of intellectual disability. In this case, a cohort of indexes [14] . Two weeks later, all mice were submitted to atVNS to assess the effect of electrostimulation. Notably, atVNS had a significant effect in novel objectrecognition memory in Fmr1KO mice compared to previous basal levels (Fmr1KO Basal = 0.065 ± 0.02; Fmr1KO atVNS = 0.21 ± 0.03, p = 0.0003), while it did not modify the performance of WT littermates (WT Basal = 0.21 ± 0.02; WT atVNS = 0.19 ± 0.02, p = 0.34)( Figure 2E) . The improvement was observed in almost every
Fmr1KO animal analyzed ( Figure 2E) . No changes were observed in the overall exploration of experimental groups at the time of the memory test ( Figure 2F ).
Discussion
This study describes a novel non-invasive transcutaneous vagus nerve stimulation method for mice with a direct impact on memory performance.
Vagus nerve stimulation has emerged as a therapy for the treatment of drugresistant epilepsy and refractory major depression, since vagal afferents onto the brainstem convey relevant inputs to numerous brain areas deregulated in both pathological states. Among those, brain regions such as the amygdala, the prefrontal cortex and the hippocampus, are also relevant for attention and memory [15] . In agreement, previous studies have revealed the modulation of memory function using invasive and non-invasive approaches of VNS in animal models and in humans [16] [17] [18] , but, to the best of our knowledge non-invasive transcutaneous approaches had not been assessed in mouse models.
We run atVNS under normothermic conditions and using a low dose of isoflurane to prevent alterations in hippocampal signaling pathways relevant for cognition [19, 20] . Our anesthesia conditions revealed no alteration of memory performance compared to non-anesthetized mice, ruling out this step as a potential bias in our behavioral results.
Notably, atVNS in the concha of the left external ear in naïve CD-1 mice improved memory retention compared to no stimulation or to sham stimulation conditions.
These results are reminiscent of previous reports in other species using invasive techniques for the enhancement of memory retention [21] and point to a potential role of endogenous modulators such as noradrenaline, which extracellular concentrations are enhanced by VNS in rodents [22, 23] . We then tested the potential of our atVNS protocol in a well-characterized mouse model of fragile X syndrome, the Fmr1KO model [7] , which shows a poor object-recognition memory which can be improved through pharmacological interventions [24, 25] , was also normalized through atVNS. Discrimination index of WT littermates was not affected after atVNS, since the novel object-recognition test presents a ceiling effect. Therefore, it is not possible to reveal an improvement in the performance of the task in models that do not display a deficit in the test phase 24 h after the familiarization phase.
Together, these results further confirm the potential of atVNS in modulating memory retention in naïve mice, and as a therapeutic tool worth exploring in the context of neurodevelopmental disorders, as previously proposed for invasive forms of VNS [26] . Future studies should focus on the cellular and molecular outcomes of atVNS to elucidate the mechanisms involved in the pro-cognitive effects of this non-invasive technique.
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Figure legends
